In the bustling world of Indian startups, few stories shine as brightly as Lenskart's. Founded in 2010 by Peyush Bansal—the affable Shark Tank India judge—the company has transformed from a scrappy online eyewear seller into a global omnichannel powerhouse. Today, as India’s eyewear market gears up for explosive growth (projected to hit $6.24 billion by 2029 with a 5.26% CAGR), Lenskart is making its stock market debut with one of 2025's most anticipated IPOs. Valued at a staggering ₹70,000 crore, this isn't just a listing; it's a bet on affordable vision for millions. But with sky-high valuations and a market hungry for the next big consumer play, is this the right lens for investors? Let's break it down.
Lenskart Solutions Limited's IPO kicked off on October 31, 2025, and runs until November 4, 2025—a four-day window that's already drawing massive buzz. Priced in the band of ₹382 to ₹402 per share, the issue totals ₹7,278 crore, split into a fresh issue of ₹2,150 crore (to fuel expansion) and an offer for sale (OFS) of ₹5,128 crore by promoters and early investors like SoftBank and Temasek.
Here's a quick snapshot:
| Parameter | Details |
|---|---|
| Issue Size | ₹7,278 crore (Fresh: ₹2,150 Cr; OFS: ₹5,128 Cr) |
| Price Band | ₹382 - ₹402 per share |
| Lot Size | 37 shares (Min. Investment: ₹14,874 at upper band) |
| Subscription Quota | QIB: 75%, NII: 15%, Retail: 10%, Employees: 5% |
| Allotment Date | November 6, 2025 |
| Listing Date | November 10, 2025 (BSE & NSE) |
| Valuation (Upper Band) | ~₹69,742 - ₹70,000 crore |
The anchor round on October 30 sealed ₹3,268 crore from heavyweights like T. Rowe Price, SBI Mutual Fund, and Goldman Sachs, signaling strong institutional faith. By the end of Day 1, the IPO was fully subscribed at 1.13x, led by QIBs (1.42x) and retail (1.31x)—a solid start amid a red-hot primary market.
Grey market premium (GMP)? It's hovering around ₹68-₹100, hinting at a 17-25% listing pop. But as always, GMP is unofficial and volatile—treat it like a foggy pair of specs.
Picture this: In a country where 80% of the population needs vision correction but organized eyewear penetration is under 20%, Peyush Bansal spotted a gap. Starting as valyoo in 2008 (rebranded to Lenskart in 2011), the company pioneered affordable, tech-driven eyewear. Today, it's the "Amazon of eyewear," blending e-commerce with 2,806 stores across India (2,137) and abroad (669 in Japan, Singapore, Thailand, and more).
Key milestones:
Backed by SoftBank (19.84% stake), Kedaara Capital, and even a pre-IPO nod from DMart's Radhakishan Damani (₹90 crore investment), Lenskart's promoter holding dips from 19.85% pre-IPO to 17.52% post-issue. Bansal's vision? Scale to 10,000 stores and dominate Southeast Asia.
Lenskart's numbers tell a tale of relentless scaling. Revenue from operations rocketed 43% YoY to ₹5,428 crore in FY24, then eased to a still-impressive 23% growth at ₹6,653 crore in FY25. EBITDA flipped from ₹403 crore (FY23) to ₹856 crore (FY24), showcasing operational muscle.
The profit story? From a ₹64 crore loss in FY23 to a slim ₹10 crore loss in FY24, then a triumphant ₹297 crore PAT in FY25—a 3,028% swing! But here's the fine print: ₹167 crore of that profit is a one-time, non-cash gain from the Owndays acquisition. Strip it out, and operational PAT lands around ₹130 crore—still a win, but not fireworks.
| Financial Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue (₹ Cr) | 3,788 | 5,428 | 6,653 |
| EBITDA (₹ Cr) | 403 | 856 | N/A |
| PAT (₹ Cr) | -64 | -10 | 297 |
| Net Worth (₹ Cr) | N/A | N/A | 6,176 |
| Borrowings (₹ Cr) | N/A | N/A | 335 |
Expenses? Employee costs up 27% to ₹1,379 crore (hire spree), materials 20% to ₹2,134 crore. International revenue: ₹2,638 crore (17% growth), with Japan at 14% of total sales. At ₹402/share, the P/E is a eyebrow-raising 260x FY25 earnings—premium pricing for a category leader, but echoes Zomato's frothy debut.
Fresh issue proceeds? Straight to growth: New company-owned stores in India, lease/rent costs, and tech upgrades (think more AI magic). Lenskart eyes India's underpenetrated market—rising incomes, smartphone penetration, and awareness could drive 5x growth. Globally? Southeast Asia's similar dynamics make it ripe for Owndays-style wins.
But risks lurk:
Bansal's retort? "My job is to create value"—citing 90% EBITDA CAGR and a moat via private labels (80% of sales).
Lenskart's IPO is a spectacle—strong brand, omnichannel scale, and a founder with flair. Day 1's full subscription and GMP pop scream enthusiasm, but at 260x P/E, it's priced for perfection, not pitfalls. Long-term bulls (5-10 years) might see Zomato-like upside in a ₹50,000 crore market. Short-term? Muted listing gains if sentiment cools.
Verdict: Subscribe for listing gains if you're retail-savvy; hold for growth if you believe in Bansal's vision. Apply via ASBA on your broker app—min lot at ₹14,874. Eyes peeled for allotment on Nov 6.
What are your thoughts on Lenskart's debut? Drop a comment—let's discuss if this IPO needs a reality check or a high-five. Until next time, stay sharp!
Disclaimer: This is not investment advice. Consult a financial advisor. Data as of November 2, 2025.
Answer:
Answer:
Answer (as of Nov 2, 2025, 5 PM):
| Category | Subscription |
|---|---|
| QIB | 1.42x |
| NII (HNI) | 0.87x |
| Retail | 1.31x |
| Overall | 1.13x |
Fully subscribed on Day 1 — strong retail & QIB interest.
Answer:
Note: GMP is speculative and not guaranteed.
Answer: Fresh issue of ₹2,150 Cr will fund:
70% of total issue is OFS — promoters & investors exiting.
Answer:
| Metric (₹ Cr) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 3,788 | 5,428 | 6,653 |
| EBITDA | 403 | 856 | N/A |
| PAT | -64 | -10 | 297 |
Key Insight: ₹167 Cr of FY25 profit is one-time non-cash gain from Owndays. Adjusted PAT: ~₹130 Cr → P/E = 260x (very expensive)
Answer:
Answer:
Analyst View:
- Swastika Investmart: Neutral – “High growth but overvalued”
- Long-term bulls: Compare to Zomato (debut at 100x P/E → now 60x)
Answer:
Answer (Balanced View):
| Apply If ✅ | Avoid If ❌ |
|---|---|
| You believe in long-term eyewear growth (5x market potential) | You want value investing (P/E < 50x) |
| Comfortable with high-risk, high-reward | Expecting 50% listing pop |
| Trust Peyush Bansal’s execution (Shark Tank credibility) | Worried about 70% OFS (early exits) |
Verdict:
- Short-term (listing gain): Possible 15–25% pop
- Long-term (3–5 yrs): High growth but monitor profitability
- Retail Strategy: Apply in 1–2 lots via ASBA; avoid leverage
Pro Tip: Use UPI mandate before 5 PM on Nov 4 to avoid last-minute glitches.